Healthcare Social Media and Updates

Oncology Revenue Dominated by Few Classes, KRAS Next.
SocialApr 6, 2026

Oncology Revenue Dominated by Few Classes, KRAS Next.

Great tables from Wedbush listing small molecule oncology and hemonc drugs ordered by approval date. I counted ~20 different classes for solid tumors and ~6 for liquid, most revenues are driven by a handful of classes that reached multi...

By Ohad Hammer
Wireless Oxygen Implant Powers Engineered Cells Inside Body
SocialApr 6, 2026

Wireless Oxygen Implant Powers Engineered Cells Inside Body

What happens when you give engineered cells their own wireless oxygen supply inside a thumb-drive-sized implant? https://spectrum.ieee.org/biologic-drugs-implant-bioelectronics-medicine?share_id=9322774

By IEEE Spectrum Threads
GLP‑1 Therapy Demands
SocialApr 6, 2026

GLP‑1 Therapy Demands

If you prescribe GLP-1s, you are not just starting a medication. You are setting expectations for a chronic disease. That is the tension at the center of this episode of The Podcast by KevinMD with obesity medicine physician Jessica Duncan. One of...

By Kevin Pho, MD
Higher BMI Predicts Late-Life Mobility and IADL Disability
SocialApr 6, 2026

Higher BMI Predicts Late-Life Mobility and IADL Disability

Late-life disability following the action for health in diabetes (Look AHEAD) trial 😷Regardless of age, those with higher BMI had increased late-life mobility and IADL disability. https://t.co/QeU9TJhf9y https://t.co/zeCNrGcO7x

By David Barzilai, MD PhD
Court Halts RFK Jr.’s Vaccine Critique—For Now
SocialApr 6, 2026

Court Halts RFK Jr.’s Vaccine Critique—For Now

https://youtu.be/zEoMQZsg2Ck?si=42IeGRta0t_Et_E1 A recent court ruling has limited RFK Jr.'s war on vaccines. At least for the moment.

By Paul Offit, MD
Collaboration Is a Skill, Not Just Meeting Attendance
SocialApr 6, 2026

Collaboration Is a Skill, Not Just Meeting Attendance

A few weeks ago I asked about your cross-functional collaboration experience in a poll. The results? Most of you work across 𝟯 𝗼𝗿 𝗺𝗼𝗿𝗲 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝘀 regularly. That's not surprising in MedTech, especially in Quality, where our work touches engineering, manufacturing, regulatory,...

By "Girl in Medtech"
AI Won’t Replace Radiologists; Demand Is Rising
SocialApr 6, 2026

AI Won’t Replace Radiologists; Demand Is Rising

Do you remember how many high-profile investors predicted that radiology would become obsolete in a few years due to the rise of AI? Yet, today, more radiologists are needed than ever. Jensen Huang, NVIDIA CEO, explains why: https://t.co/d4lpdMGJhO

By Bertalan Meskó, PhD
Psilocybin Single Dose Beats Nicotine Patches for Quitting
SocialApr 6, 2026

Psilocybin Single Dose Beats Nicotine Patches for Quitting

A single dose of psilocybin is more effective than nicotine patches for quitting smoking, study suggests https://t.co/APDQt1WYxp https://t.co/zDnXcUjFyG

By David Barzilai, MD PhD
Nvidia's Nurabot Deploys in Hospitals to Aid Staff
SocialApr 6, 2026

Nvidia's Nurabot Deploys in Hospitals to Aid Staff

Nvidia’s Nurabot Rolls Into Hospitals to Assist #Healthcare Workers by @CyberRobooo #MedTech #HealthTech #TechForGood #Tech https://t.co/TJc2q039WA

By Ron van Loon
China Deploys Robots to Revolutionize Elderly Care
SocialApr 6, 2026

China Deploys Robots to Revolutionize Elderly Care

China's Robot-Run Elderly Care Centre | AI Caregiving | Tech It Out https://t.co/pK7nFvmJQu via @YouTube #eldercare #healthcare #humanoidtech #humanoid #robot #Robotics #AI #TechRevolution #TechInnovation #ArtificialInteligence #PhysicalAI @AlbertoEMachado @Eli_Krumova @postoff25 @Khulood_Almani @anand_narang @NutritiousMind @baski_LA @TanyaSinha_ @devaang @AlAmadi1 @jeancayeux @enilev @efipm @mvollmer1 @Nicochan33 @RagusoSergio...

By Amitav Bhattacharjee
SIRT1 Activation Shows Promise for Age‑related Brain Disorders
SocialApr 5, 2026

SIRT1 Activation Shows Promise for Age‑related Brain Disorders

SIRT1 Activators as Geroprotective Agents in Brain Aging: Mechanisms and Therapeutic Potential "...SIRT1 could be a promising pharmacological target for age-associated brain disorders, warranting more robust translational studies to validate these findings in humans..." https://t.co/hGVxZ4RErM

By David Barzilai, MD PhD
Unexplained Infertility Often Means Under‑investigated; Get Expanded Testing
SocialApr 5, 2026

Unexplained Infertility Often Means Under‑investigated; Get Expanded Testing

Unexplained infertility means the standard tests came back normal. It does not mean nothing is wrong. It means the tests they ran did not find anything. Most standard fertility workups check AMH, FSH, an ultrasound, and maybe TSH. They do not...

By Preethi Kasireddy
Whiteboard Tactics Unlock NHS Negotiation Success
SocialApr 5, 2026

Whiteboard Tactics Unlock NHS Negotiation Success

The Whiteboard Windfall: A Lesson in NHS Negotiations by @Timothy_Hughes https://t.co/2JqnBxsbKP @DLAIgnite #SocialSelling #DigitalSelling #Sales #SalesTips #SalesLeader #Salesforce #SalesEnablement #RevOps #Leadership #Marketing #SalesNegotiation https://t.co/y7GD77iyVR

By Tim Hughes
Veteran Male Athletes Face Heightened Ventricular Tachycardia Risk
SocialApr 5, 2026

Veteran Male Athletes Face Heightened Ventricular Tachycardia Risk

Protecting older male athletes’ heart health “Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while exercising, new University of Leeds research shows… Over the two years of the study, around...

By David Barzilai, MD PhD
AI May Outperform PBMs in Transparent Healthcare Pricing
SocialApr 5, 2026

AI May Outperform PBMs in Transparent Healthcare Pricing

Serious ? Who would you trust more for personal healthcare information, @chatgpt, @claudeai , @GeminiApp , @grok Or the PBMs and Insurance companies you have integrated into your EHR ? Yes you do a better job of protecting PHII, but that’s not...

By Mark Cuban
Obesity and Age Drive Peripheral Inflammation in Cognitive Impairment
SocialApr 5, 2026

Obesity and Age Drive Peripheral Inflammation in Cognitive Impairment

Peripheral inflammation in a Canadian cohort of neurodegenerative conditions: Occurrence, determinants, and impact "Peripheral low-grade inflammation was common, particularly in individuals with cognitive impairment; and obesity and age were the main drivers..." https://t.co/KvjFleW6t4

By David Barzilai, MD PhD
Cures Emerge From Incremental Advances, Not Single Breakthroughs
SocialApr 5, 2026

Cures Emerge From Incremental Advances, Not Single Breakthroughs

The media makes it seem like cures are one breakthrough away. In reality, cures come from smaller breakthroughs and improvements made by the work of thousands of scientists, drug developers and doctors. We’re witnessing this evolution in real time with...

By David Sinclair, PhD
Attia Endorses Statins for 30‑year‑olds Despite Modest Benefits
SocialApr 5, 2026

Attia Endorses Statins for 30‑year‑olds Despite Modest Benefits

So @PeterAttiaMD really loves statins and now leans into it for 30YO. This stance always surprised me given the low improvement rates of death and statin side effects. https://t.co/hV3kF44fr2

By Patrick Moorhead
Treat Underlying Health Issues Before Defaulting to IVF
SocialApr 5, 2026

Treat Underlying Health Issues Before Defaulting to IVF

IVF is an incredible technology. It has given millions of families children they would not have had otherwise. But it has also become the default recommendation for any woman who has been trying for more than a year, often without...

By Preethi Kasireddy
One Daily Drink Ages Brain by Two Years
SocialApr 5, 2026

One Daily Drink Ages Brain by Two Years

As a medical school professor, I need to be honest: there is no safe level of alcohol for your brain. A landmark study of 36,000 brain scans found that even one drink per day shrinks your brain -- and the damage...

By Robert Lufkin, MD
Risk-Weighted ApoB Outperforms LDL in CVD Prediction
SocialApr 5, 2026

Risk-Weighted ApoB Outperforms LDL in CVD Prediction

LDL is only part of the equation. What's your Lp(a), VLDL, ApoB? Risk-weighted ApoB, which incorporates all of the above, is a better measure than LDL for predicting CVD risk: https://t.co/y5Hc9ZXIWG

By Michael Lustgarten, PhD
Daratumumab Boosts Revlimid Efficacy in Smoldering Myeloma
SocialApr 5, 2026

Daratumumab Boosts Revlimid Efficacy in Smoldering Myeloma

#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie https://t.co/VtBMJUjI5X Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd https://t.co/fFVUqNssyX

By Mike Thompson, MD PhD
Phase 3 Trial Tests Daratumumab
SocialApr 5, 2026

Phase 3 Trial Tests Daratumumab

.@SWOG S2213 Ph3 RCT Dara-VC Induction Followed by ASCT or Dara-VCD Consolidation & Daratumumab Maintenance in Pts w/ Newly Diagnosed AL Amyloidosis [Activated: 12/1/23] https://t.co/OizUfJCc2c #mmsm #bmtsm https://t.co/ClwxVAhSy0

By Mike Thompson, MD PhD
Psychedelics Show Promise for Schizophrenia Negative Symptoms
SocialApr 5, 2026

Psychedelics Show Promise for Schizophrenia Negative Symptoms

Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review https://t.co/fGpTLwF3DK

By Julie Holland
Women Need Their Own Longevity Blueprint, Not Male Models
SocialApr 5, 2026

Women Need Their Own Longevity Blueprint, Not Male Models

Women are not “mini-men.” That line from Dr. Jennifer Pearlman MD CCFP NCMP FAARM ABAARM stuck with me from our @Optispan_Inc Podcast conversation—and it sets the stage for a much bigger issue. For decades, medicine and biomedical research have often treated...

By Matt Kaeberlein, PhD
Expensive AR Headsets Offer No Clear Advantage over Smartphones
SocialApr 5, 2026

Expensive AR Headsets Offer No Clear Advantage over Smartphones

The story is wonderful: a UK hospital is using augmented reality during pre-surgical consultations to let patients view anatomically precise 3D models through a headset and see what might be happening inside their bodies. But is it really the way forward? There...

By Bertalan Meskó, PhD
Just Culture Turns Shame Into Safety After Harm
SocialApr 5, 2026

Just Culture Turns Shame Into Safety After Harm

The culture of a hospital is revealed most clearly after a patient is harmed. Not when the case goes well. Not when the metrics look good. After the adverse event. In this episode of The Podcast by KevinMD, Scott Ellner @Surgeryquality describes what too...

By Kevin Pho, MD
Congress Must Reform Broken IND Process for FIH Trials
SocialApr 5, 2026

Congress Must Reform Broken IND Process for FIH Trials

Great to see FDA & the administration prioritizing FIH (First in Human) reform. The current IND process is broken & has shifted FIH trials overseas. Countries like Australia have relied on a more flexible, notification-based pathway for years. Now Congress...

By Robert Nelsen
Statins Now Recommended for Patients as Young as 30
SocialApr 5, 2026

Statins Now Recommended for Patients as Young as 30

Updated cardiovascular guidelines—statin use in patients as young as 30 Recommendations still may not be aggressive enough, but the needle is moving https://t.co/HS9PtEdrsU https://t.co/d9YcDAFH2N

By David Barzilai, MD PhD
Krugman, Kahn Overlook Core Issue in Drug Debate
SocialApr 5, 2026

Krugman, Kahn Overlook Core Issue in Drug Debate

When it comes to talking about prescription drugs, Paul Krugman and Lina Kahn missed the big picture https://t.co/U1YXMQ2Lk8

By Dean Baker
Targeted Antivirals and Vaccines Needed for CMV-Linked Cognitive Decline
SocialApr 5, 2026

Targeted Antivirals and Vaccines Needed for CMV-Linked Cognitive Decline

Human cytomegalovirus infection and cognitive decline: insights from population and experimental studies 🔎"We advocate for targeted antiviral strategies and vaccine development to clarify its contribution to neurodegeneration." https://t.co/b7Qx9aj0K3 https://t.co/KMB9ITLEzW

By David Barzilai, MD PhD
New Leaders Aim to Expand Colorado Health Access, Cut Costs
SocialApr 4, 2026

New Leaders Aim to Expand Colorado Health Access, Cut Costs

Thrilled to welcome Stephanie Beasley and Gretchen Hammer to these roles. Their leadership will strengthen Colorado as we expand access and lower costs for physical and mental health care. https://www.colorado.gov/governor/news/governor-polis-makes-cabinet-announcement

By Governor Jared Polis
White House FY27 Budget Slashes ARPA-H Funding by Half
SocialApr 4, 2026

White House FY27 Budget Slashes ARPA-H Funding by Half

At the same time the White House proposed FY27 budget recommends cutting almost half of the ARPA-H budget

By Angela Rasmussen
AI-Powered Robot Performs Fully Autonomous Blood Draws
SocialApr 4, 2026

AI-Powered Robot Performs Fully Autonomous Blood Draws

World’s First Autonomous Blood-Drawing #Robot Uses #AI to Find Veins and Collect Blood Automatically by @Berci #MedTech #Healthcare #HealthTech #Tech #Technology https://t.co/fQdjp2ubdz

By Ron van Loon
GLP‑1s Linked to Lower Risk of Mental Illness Worsening
SocialApr 4, 2026

GLP‑1s Linked to Lower Risk of Mental Illness Worsening

GLP-1s appear to reduce the odds of mental illness getting worse. Another unlooked-for benefit. Caveats: 1. This is observational, not an RCT. 2. This is reduction of odds getting worse on each of these measures. Not reduction of existing mental illness....

By Ramez Naam
GLP‑1s Massively Marked up; LLMs Priced Near Cost
SocialApr 4, 2026

GLP‑1s Massively Marked up; LLMs Priced Near Cost

One observation here: GLP-1s are priced at maybe 25-50x production cost (not counting R&D). LLM usage is priced at perhaps 1x inference cost (not counting training). In any case, two great innovations that are rapidly catching on.

By Ramez Naam
Cut High‑paid Admins, Not Tech, to Improve Care
SocialApr 4, 2026

Cut High‑paid Admins, Not Tech, to Improve Care

If we got rid of hospital administrators paid multimillion dollar salaries that would be a lot better than letting them destroy care with Silicon Valley snake oil. https://t.co/F2gpwYJOPq

By Matt Stoller
China Competition Will Accelerate US Pharma, Cut Red Tape
SocialApr 4, 2026

China Competition Will Accelerate US Pharma, Cut Red Tape

This is great to see. Biotech and pharma competition with China is going to force us to sharpen and accelerate processes in the US, and cut red tape. And we'll get the benefit of Chinese drugs as well. Win/win.

By Ramez Naam
Exercise Mitigates Motor Unit Decline During Bedrest in Seniors
SocialApr 4, 2026

Exercise Mitigates Motor Unit Decline During Bedrest in Seniors

Exercise during 14 days of head down tilt bedrest attenuates motor unit impairments in older humans https://t.co/LOCU5ppBxh @ExpPhysiol https://t.co/0sdUCLOqP7

By David Barzilai, MD PhD
Insurers and AI Firms Secretly Record Therapy to Cut Costs
SocialApr 4, 2026

Insurers and AI Firms Secretly Record Therapy to Cut Costs

Yes, health insurer and Silicon Valley owned AI companies are taping therapy sessions and using that data. It's a creepy situation driven by health insurers not wanting to pay for mental health care. https://t.co/zLyh5fcdvr

By Matt Stoller
Cash‑pay GLP‑1 Clinics: Easy to Copy, Unsafe, Unregulated
SocialApr 4, 2026

Cash‑pay GLP‑1 Clinics: Easy to Copy, Unsafe, Unregulated

By now we have all read the piece in @nytimes about MEDVi's $1B+ business selling GLP-1s online with a ton of marketing, and very little ownership of infrastructure. I asked two friends @josh_tauber and @keatonbedell: - Is there any moat? (no) -...

By Christina Farr
Five Tech Giants Roll Out AI Health Chatbots, Journalist Tests
SocialApr 4, 2026

Five Tech Giants Roll Out AI Health Chatbots, Journalist Tests

This year 5 tech companies have introduced AI chatbots to consumers for health support @AnthropicAI @perplexity_ai @OpenAI @Microsoft @amazon @nicnguyen, a @WSJ journalist, tried some out. gift link https://t.co/vwO261Q6qB https://t.co/VFPyvc1P9O

By Eric Topol
Optimal Vitamin D (50‑70) Boosts Fertility Outcomes
SocialApr 4, 2026

Optimal Vitamin D (50‑70) Boosts Fertility Outcomes

Most doctors will tell you your vitamin D is fine if it is above 30. That is not enough for fertility. Vitamin D receptors are on your ovarian follicles, your uterine lining, and your placenta. Women with levels above 30 ng/mL...

By Preethi Kasireddy
Intermittent Fasting Cuts Crohn’s Disease Activity by 40%
SocialApr 4, 2026

Intermittent Fasting Cuts Crohn’s Disease Activity by 40%

As a medical school professor, I was never taught this: meal timing may be more powerful than medication for gut disease. A new clinical trial in Gastroenterology found that intermittent fasting reduced Crohn's disease activity by 40%. Patients who restricted eating to...

By Robert Lufkin, MD
Rhizopus Microsporus Linked to COVID-19 Mucormycosis Case
SocialApr 4, 2026

Rhizopus Microsporus Linked to COVID-19 Mucormycosis Case

Anyone have access to this paper? Rhizopus microsporus as Causative Agent of Mucormycosis in COVID-19 Patient https://t.co/Ao0uPXhzPY

By Michael Lustgarten, PhD
Key Needs of Ovarian Cancer Survivors Highlighted
SocialApr 4, 2026

Key Needs of Ovarian Cancer Survivors Highlighted

The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat [Apr 26, 2018] @TLHagan et al. @JPCRR https://t.co/dOHPGvQ9Zy

By Mike Thompson, MD PhD
COVID-19 Outcomes Worse for Gynecologic Cancer Patients
SocialApr 4, 2026

COVID-19 Outcomes Worse for Gynecologic Cancer Patients

COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium [Mar 16, 2026] @AlainaJBrown et al. @COVID19nCCC @JCOOA_ASCO https://t.co/lZU3hFiNSS #gyncsm #CCC19 #COVID19nCancer #COVID19 https://t.co/mG18P0SHk3

By Mike Thompson, MD PhD
Recent Cancer Treatments Linked to Worse COVID-19 Outcomes
SocialApr 4, 2026

Recent Cancer Treatments Linked to Worse COVID-19 Outcomes

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology https://t.co/WH5PPJySj6 #CCC19 #COVID19nCancer https://t.co/WN6maEUppn

By Mike Thompson, MD PhD
Diet Sodas Raise Liver Disease Risk as Much as Sugar
SocialApr 4, 2026

Diet Sodas Raise Liver Disease Risk as Much as Sugar

As a medical school professor, I need to warn you: "diet" drinks may be just as dangerous as sugary ones for your liver. A major UK Biobank study of 124,000 people found: -- Artificially sweetened drinks raised liver disease risk by 60% --...

By Robert Lufkin, MD